| 中國醫藥大學 |
2006-12-23 |
Vancomycin引起之嗜中性白血球減少症
|
楊蕙菁; 鍾尚容; 潘美如; 林明薰; 鄞玉娟; 郭啟文* |
| 國家衛生研究院 |
2023 |
Vancomycin治療伊莉莎白菌之體外、動物、臨床效果，與殺菌作用機轉之探究
|
郭書辰 |
| 國立成功大學 |
2024-07-16 |
Vancomycin波谷濃度與急性腎損傷之間的風險因子研究
|
曾湘涵; Tseng, Siang-Han |
| 臺大學術典藏 |
2018-09-10T05:57:47Z |
Vandermonde-form preserving matrices and the generalized signal richness preservation problem
|
Su, B.; Vaidyanathan, P.P.; BORCHING SU |
| 臺大學術典藏 |
2022-08-19T00:20:57Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Cheng A.-L.; Meng R.; Chao Y.; Hsieh T.-Y.; Huang W.-T.; Hwang W.-S.; Yu C.-W.; Hsieh R.-K.; Huo T.-I.; Yang T.-S.; CHIUN HSU |
| 國立臺灣大學 |
2012 |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Hsu, Chiun; Yang, Tsai-Sheng; Huo, Teh-Ia; Hsieh, Ruey-Kuen; Yu, Chih-Wei; Hwang, Wei-Shou; Hsieh, Tsai-Yuan; Huang, Wen-Tsung; Chao, Yee; Meng, Robin; Cheng, Ann-Lii; 鄭安理; 許駿; 游治維 |
| 臺大學術典藏 |
2018-09-10T09:15:01Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Hsu, C. and Yang, T.-S. and Huo, T.-I. and Hsieh, R.-K. and Yu, C.-W. and Hwang, W.-S. and Hsieh, T.-Y. and Huang, W.-T. and Chao, Y. and Meng, R. and Cheng, A.-L.; Hsu, Chiun;Yang, Tsai-Sheng;Huo, Teh-Ia;Hsieh, Ruey-Kuen;Yu, Chih-Wei;Hwang, Wei-Shou;Hsieh, Tsai-Yuan;Huang, Wen-Tsung;Chao, Yee;Meng, Robin;Cheng, Ann-Lii; 鄭安理 ;許駿 ;游治維; CHIH-WEI YU; Hsu, Chiun; ANN-LII CHENG; Yang, Tsai-Sheng; Huo, Teh-Ia; Hsieh, Ruey-Kuen; Yu, Chih-Wei; Hwang, Wei-Shou; Hsieh, Tsai-Yuan; Huang, Wen-Tsung; Chao, Yee; Meng, Robin; Cheng, Ann-Lii |
| 臺大學術典藏 |
2020-04-10T12:51:14Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Chiun Hsu;Yang T.-S.;Huo T.-I.;Hsieh R.-K.;Yu C.-W.;Hwang W.-S.;Hsieh T.-Y.;Huang W.-T.;Chao Y.;Meng R.;Cheng A.-L.; Chiun Hsu; Yang T.-S.; Huo T.-I.; Hsieh R.-K.; Yu C.-W.; Hwang W.-S.; Hsieh T.-Y.; Huang W.-T.; Chao Y.; Meng R.; Cheng A.-L. |
| 臺大學術典藏 |
2020-07-09T02:57:03Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
CHIH-WEI YU; Hwang W.-S.; Hsieh T.-Y.; Huang W.-T.; Chao Y.; Meng R.; Cheng A.-L.; Hsieh R.-K.; Huo T.-I.; Yang T.-S.; Hsu C. |
| 臺大學術典藏 |
2021-09-01T01:54:01Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Hsu C.; Yang T.-S.; Huo T.-I.; Hsieh R.-K.; Yu C.-W.; Hwang W.-S.; Hsieh T.-Y.; Huang W.-T.; Chao Y.; Meng R.; ANN-LII CHENG |
| 臺大學術典藏 |
2020-05-26T09:27:14Z |
Vandetanib plus pemetrexed for the second-line treatment of advanced non - small-cell lung cancer: A randomized, double-blind phase III trial
|
De Boer R.H;Arrieta ?;Chih-Hsin Yang;Gottfried M;Chan V;Raats J;De Marinis F;Abratt R.P;Wolf J;Blackhall F.H;Langmuir P;Milenkova T;Read J;Vansteenkiste J.F.; De Boer R.H; Arrieta ?; CHIH-HSIN YANG; Gottfried M; Chan V; Raats J; De Marinis F; Abratt R.P; Wolf J; Blackhall F.H; Langmuir P; Milenkova T; Read J; Vansteenkiste J.F. |
| 國立臺灣大學 |
2011 |
Vandetanib Plus Pemetrexed for the Second-Line Treatment of Advanced Non- Small-Cell Lung Cancer: A Randomized, Double-Blind Phase Iii Trial
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Vandetanib Plus Pemetrexed Versus Pemetrexed as Second-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer (Nsclc): A Randomized, Double-Blind Phase Iii Trial (Zeal)
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Vandetanib Plus Pemetrexed Vs Pemetrexed as 2nd-Line Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (Nsclc); a Randomized, Double- Blind Phase Iii Trial
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Vandetanib Plus Pernetrexed Versus Pemetrexed as 2nd-Line Therapy in Patients with Advanced Nsclc: A Randomized, Double-Blind Phase Iii Trial ( Zeal)
|
楊志新; YANG, CHIH-HSIN |
| 臺大學術典藏 |
2019-12-19T07:12:49Z |
Vane shear behavior of soft Bangkok clay
|
Seah, T. H.; Note, S. T.; Chan, I. C.; I-CHI CHAN |
| 國立臺灣科技大學 |
2014 |
VANET-based secure value-added services
|
Horng, S.-J.;Tzeng, S.-F. |
| 國立屏東大學 |
2012 |
VANET分層式網路架構路由研究
|
施釗德;林志勳;蔡承軒 |
| 國立臺中教育大學 |
2003 |
vanHiele幾何思考的評量方式比較與後設認知之研究
|
陳淑惠; Chen, Shu-Hui |
| 高雄醫學大學 |
1997 |
Vanidilol : a vanilloid type vasorlaxant and ocular hypotensive β-adrenoceptor blocker with partial β2 agonist activity
|
明木,吳炳男,何婉青,洪秀貞,陳雪君,林永哲,陳英俊 |
| 高雄醫學大學 |
1997 |
Vanidilol: a vanilloid type vasorlaxant and ocular hypotensive β-adrenoceptor block with partial β2 agonist activity
|
明木;吳炳男;何婉青;洪秀貞;陳 雪君;林永哲;陳英俊 |
| 高雄醫學大學 |
1997 |
Vanidilol: a vanilloid type vasorlaxant and ocular hypotensive β-adrenoceptor block with partial β2 agonist activity
|
許明木;吳炳男;何婉青;洪秀貞;陳 雪君;林永哲;陳英俊 |
| 高雄醫學大學 |
1997 |
Vanidilol: a vanilloid type vasorlaxant and ocular hypotensive β-adrenoceptor block with partial β2 agonist activity
|
許明木;吳炳男;何婉青;洪秀貞;雪君, 陳;林永哲;陳英俊 |
| 輔英科技大學 |
1997-04-01 |
Vanidilol: A Vanilloid-Type Vasorelaxant and Ocular Hypotensive Beta-Adrenoceptor Blocker with Partial Beta-2-Agonist Activity.
|
Min-Muh Sheu;Bin-Nan Wu;Wong-Ching Ho;Show-Jen Hong;Sheue-Jiun Chen;Young-Tso Lin;Ing-Jun Chen |
| 高雄醫學大學 |
2000 |
Vanidipinedilol: 一個以Vanilloid為骨架且具有阻斷鈣離子通道及血管擴張活性之乙型腎上腺素性受體阻斷劑
|
葉竹來;劉淑芬;梁至中;黃允志;蔣連財;吳俊仁;林永哲;陳英俊 ; Jwu-Lai Yeh;Shwu-Fen Liou;Jyh-Chong Liang;Yeun-Chih Huang;Lien-Chai Chiang;Jiunn-Ren Wu;Young-Tso Lin;Ing-Jun Chen |
